| abstract |
The present application relates to glutaminase inhibitors. The present disclosure provides compounds of formulae (I) to (III) as glutaminase inhibitors, methods for their preparation, pharmaceutical compositions containing these compounds, and the treatment, prevention and/or amelioration of diseases involving glutamine or method of illness. |